{"id":"https://openalex.org/W2106862355","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2042","title":"Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma","display_name":"Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma","alternate_titles":[],"publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W2106862355","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2042","mag":"2106862355","pmid":"https://pubmed.ncbi.nlm.nih.gov/19435839"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-08-2042","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2042","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-08-2042","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2106862355"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108685210","display_name":"Jean\u2010S\u00e9bastien Guillamo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Se\u0301bastien Guillamo","raw_affiliation_strings":["1INSERM Unit 421 Plasticite\u0301 ce\u0301re\u0301brale et the\u0301rapeutique, Cre\u0301teil, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM Unit 421 Plasticite\u0301 ce\u0301re\u0301brale et the\u0301rapeutique, Cre\u0301teil, France;","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110004987","display_name":"Sophie de Bo\u00fcard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sophie de Bou\u0308ard","raw_affiliation_strings":["1INSERM Unit 421 Plasticite\u0301 ce\u0301re\u0301brale et the\u0301rapeutique, Cre\u0301teil, France;","2GRECAN;","GRECAN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM Unit 421 Plasticite\u0301 ce\u0301re\u0301brale et the\u0301rapeutique, Cre\u0301teil, France;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"2GRECAN;","institution_ids":[]},{"raw_affiliation_string":"GRECAN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075946256","display_name":"Samuel Valable","orcid":"https://orcid.org/0000-0003-0355-0270","observed_orcids":["https://orcid.org/0000-0003-0355-0270"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Samuel Valable","raw_affiliation_strings":["3UMR 6232 CI-NAPS;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UMR 6232 CI-NAPS;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008932759","display_name":"L\u00e9na Marteau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lena Marteau","raw_affiliation_strings":["3UMR 6232 CI-NAPS;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UMR 6232 CI-NAPS;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012482068","display_name":"Pascal Leuraud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4405276994","display_name":"Biologie des Interactions Neurones/Glie","ror":"https://ror.org/0135ryh97","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4405264447","https://openalex.org/I4405276994"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pascal Leuraud","raw_affiliation_strings":["5INSERM Unit 495 Laboratoire de biologie des interactions neurones-glie;","6FRE 2584 CNRS, Institut Curie, Paris, France; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5INSERM Unit 495 Laboratoire de biologie des interactions neurones-glie;","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405276994"]},{"raw_affiliation_string":"6FRE 2584 CNRS, Institut Curie, Paris, France; and","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904721","display_name":"Yannick Marie","orcid":"https://orcid.org/0009-0009-8424-2640","observed_orcids":["https://orcid.org/0009-0009-8424-2640"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4405276994","display_name":"Biologie des Interactions Neurones/Glie","ror":"https://ror.org/0135ryh97","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4405264447","https://openalex.org/I4405276994"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yannick Marie","raw_affiliation_strings":["5INSERM Unit 495 Laboratoire de biologie des interactions neurones-glie;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5INSERM Unit 495 Laboratoire de biologie des interactions neurones-glie;","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405276994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108549825","display_name":"Marie\u2010France Poupon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie-France Poupon","raw_affiliation_strings":["6FRE 2584 CNRS, Institut Curie, Paris, France; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6FRE 2584 CNRS, Institut Curie, Paris, France; and","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029201551","display_name":"Jean\u2010Jacques Parienti","orcid":"https://orcid.org/0000-0002-4774-5590","observed_orcids":["https://orcid.org/0000-0002-4774-5590"]},"institutions":[{"id":"https://openalex.org/I4210114068","display_name":"Centre Hospitalier Universitaire de Caen Normandie","ror":"https://ror.org/027arzy69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210114068"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Jacques Parienti","raw_affiliation_strings":["4Unite\u0301 de Recherche Clinique, CHU de Caen, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Unite\u0301 de Recherche Clinique, CHU de Caen, France;","institution_ids":["https://openalex.org/I4210114068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013952219","display_name":"\u00c9ric Raymond","orcid":"https://orcid.org/0000-0001-5491-2708","observed_orcids":["https://orcid.org/0000-0001-5491-2708"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric Raymond","raw_affiliation_strings":["7De\u0301partement de Me\u0301decine, Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7De\u0301partement de Me\u0301decine, Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084576487","display_name":"Marc Peschanski","orcid":"https://orcid.org/0000-0001-9966-3282","observed_orcids":["https://orcid.org/0000-0001-9966-3282"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Peschanski","raw_affiliation_strings":["1INSERM Unit 421 Plasticite\u0301 ce\u0301re\u0301brale et the\u0301rapeutique, Cre\u0301teil, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM Unit 421 Plasticite\u0301 ce\u0301re\u0301brale et the\u0301rapeutique, Cre\u0301teil, France;","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3258,"has_fulltext":false,"cited_by_count":79,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94722645,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"15","issue":"11","first_page":"3697","last_page":"3704"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.7730000019073486},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.828000009059906},{"id":"https://openalex.org/keywords/high-grade-glioma","display_name":"high-grade glioma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/egfr-amplification","display_name":"EGFR amplification","score":0.8939999938011169},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9110000133514404},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.7329999804496765},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.7760000228881836},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.6610000133514404},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7739999890327454},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.8379999995231628},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.36000001430511475},{"id":"https://openalex.org/keywords/erk","display_name":"ERK","score":0.8019999861717224},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.800000011920929},{"id":"https://openalex.org/keywords/cdkn2a","display_name":"CDKN2A","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9563332796096802},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.8898590803146362},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7608386278152466},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7167099118232727},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6472877860069275},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.6012876629829407},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5901027917861938},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5130878686904907},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.49291276931762695},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.48361340165138245},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.46615728735923767},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.4265179932117462},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3492816686630249},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.33096325397491455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3308722674846649},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3303241431713104},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3241844177246094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20073017477989197},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.06397169828414917}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009924","descriptor_name":"Organ Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019941","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p16","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019941","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p16","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048049","descriptor_name":"Extracellular Signal-Regulated MAP Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-08-2042","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2042","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-08-2042","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:19435839","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19435839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1519698040","https://openalex.org/W1523413020","https://openalex.org/W1528559061","https://openalex.org/W1532046735","https://openalex.org/W1575973365","https://openalex.org/W1576158911","https://openalex.org/W1659037751","https://openalex.org/W1911965864","https://openalex.org/W1964510683","https://openalex.org/W1973071934","https://openalex.org/W1974024530","https://openalex.org/W1975306522","https://openalex.org/W1984284981","https://openalex.org/W1987413233","https://openalex.org/W1987797739","https://openalex.org/W1991373685","https://openalex.org/W1994629976","https://openalex.org/W1999614615","https://openalex.org/W2001598945","https://openalex.org/W2002943210","https://openalex.org/W2013878898","https://openalex.org/W2028415754","https://openalex.org/W2043696829","https://openalex.org/W2049229287","https://openalex.org/W2052420703","https://openalex.org/W2056535857","https://openalex.org/W2067069698","https://openalex.org/W2070705072","https://openalex.org/W2079977894","https://openalex.org/W2098341282","https://openalex.org/W2103612830","https://openalex.org/W2110425570","https://openalex.org/W2117941094","https://openalex.org/W2122656686","https://openalex.org/W2125096000","https://openalex.org/W2126314379","https://openalex.org/W2140375000","https://openalex.org/W2143536404","https://openalex.org/W2143739956","https://openalex.org/W2148345901","https://openalex.org/W2150037470","https://openalex.org/W2154391976","https://openalex.org/W2154670277","https://openalex.org/W2155977433","https://openalex.org/W2156709380","https://openalex.org/W2157270051","https://openalex.org/W2160511594","https://openalex.org/W2163147844","https://openalex.org/W2167823712","https://openalex.org/W2240745411","https://openalex.org/W2391415472","https://openalex.org/W4211075026","https://openalex.org/W4244344354"],"related_works":["https://openalex.org/W2327983157","https://openalex.org/W1848898216","https://openalex.org/W2034207796","https://openalex.org/W2107132417","https://openalex.org/W2160511594","https://openalex.org/W2279018385","https://openalex.org/W1998670627","https://openalex.org/W2138549910","https://openalex.org/W2130743783"],"abstract_inverted_index":{"PURPOSE:":[0],"Epidermal":[1],"growth":[2],"factor":[3],"receptor":[4],"(EGFR)":[5],"signal":[6],"transduction":[7],"pathways":[8],"are":[9],"implicated":[10],"in":[11,36,51,67,123,155,160,169,211,221],"malignant":[12,69,85],"glioma":[13],"aggressiveness":[14],"and":[15,21,97,99,104,135],"promote":[16],"tumor":[17,65,147],"cell":[18,148,219],"invasion,":[19,133],"proliferation,":[20,134],"angiogenesis.":[22,136],"Nevertheless,":[23],"response":[24],"to":[25,61,183,230],"EGFR":[26,141,158,175,203,222,246],"tyrosine":[27],"kinase":[28,204],"inhibitor":[29],"gefitinib":[30,62,111,241],"(Iressa,":[31],"ZD1839)":[32],"has":[33],"been":[34],"disappointing":[35],"clinical":[37],"trials.":[38],"One":[39],"potential":[40],"explanation":[41],"may":[42],"come":[43],"from":[44,87],"the":[45,191,197,202,214,245,250],"diversity":[46],"of":[47,82,132,171,190,196,201,213,227,234,238,249],"molecular":[48,74,100],"alterations":[49],"seen":[50],"gliomas.":[52],"To":[53],"validate":[54],"that":[55,71,129],"hypothesis,":[56],"we":[57],"have":[58],"investigated":[59],"responses":[60],"on":[63,244],"various":[64],"parameters":[66],"human":[68,84],"gliomas":[70,86],"exhibited":[72],"different":[73],"alterations.":[75,106],"EXPERIMENTAL":[76],"DESIGN:":[77],"We":[78,185],"used":[79],"a":[80,161,232],"panel":[81],"six":[83],"established":[88],"xenografts":[89],"characterized":[90],"for":[91,116],"their":[92],"genetic":[93,247],"(EGFR,":[94,101],"PTEN,":[95,102],"TP53,":[96],"CDKN2A)":[98],"ERK,":[103],"Akt)":[105],"Tumors":[107,177],"were":[108,181],"treated":[109],"with":[110,145,157,174,178],"(1":[112],"or":[113,120],"10":[114],"micromol/L)":[115],"prolonged":[117],"periods":[118],"(8":[119],"16":[121],"days)":[122],"an":[124],"organotypic":[125],"brain":[126],"slice":[127],"model":[128],"allowed":[130],"quantification":[131],"RESULTS:":[137],"In":[138],"nontreated":[139],"tumors,":[140],"amplification":[142,159],"was":[143,153],"associated":[144],"profuse":[146],"invasion.":[149],"After":[150],"treatment,":[151],"invasion":[152,220],"inhibited":[154],"tumors":[156,173,192,198],"dose-dependent":[162],"manner.":[163],"Treatment":[164],"had":[165,199,207],"only":[166],"antiproliferative":[167],"effect":[168,210],"two":[170],"three":[172],"amplification.":[176],"PTEN":[179,225],"loss":[180,226],"resistant":[182],"treatment.":[184,194],"did":[186],"not":[187],"observe":[188],"shrinkage":[189],"after":[193],"None":[195],"mutations":[200],"domain.":[205],"Gefitinib":[206,217],"similar":[208],"antiangiogenic":[209],"all":[212],"tumors.":[215,224,251],"CONCLUSIONS:":[216],"reduces":[218],"amplified":[223],"expression":[228],"seems":[229,242],"be":[231],"determinant":[233],"resistance.":[235],"Interestingly,":[236],"inhibition":[237],"angiogenesis":[239],"by":[240],"independent":[243],"status":[248]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2106862355","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
